- 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-nerve-block-protocol.pdf
November 18, 2023 - and neurovascular responses, cardiac 
stress, and a longer physiologic surgical stress response.5–8 Opioids … are the mainstay of acute 
postoperative pain management.9,10 However, opioids are associated not only … Opioids Prescribed After Low-Risk 
Surgical Procedures in the United States, 2004-2012. … In-hospital use of 
opioids increases rate of coded postoperative paralytic ileus. … BOPv1U
undergoing surgery: unequal burden on younger girls with higher doses of opioids.
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
August 01, 2020 - Participants were still considered 
retained in MAT if they continued to use illicit opioids or missed … Unlike naltrexone, buprenorphine 
does not require a period of complete abstinence from opioids to initiate … of XR-naltrexone and other antagonist therapies that 
require a period of complete abstinence from opioids … Script in a Day intervention for individuals 
who are injecting opioids: a feasibility 
randomized control … Effects of 
medication-assisted treatment on mortality 
among opioids users: a systematic review 
and
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/living-systematic-reviews-full-text-articles-white-paper.pdf
January 01, 2024 - In the case of opioids,5 
serious potential harms include risk of opioid use disorder and overdose. … CDC 
guideline for prescribing opioids for chronic 
pain– United States, 2016. … CDC 
guideline for prescribing opioids for chronic 
pain - United States, 2016. … Concomitant cannabis abuse/dependence in 
patients treated with opioids for non-cancer 
pain. … Concomitant cannabis abuse/dependence in 
patients treated with opioids for non-cancer 
pain.
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
May 01, 2011 - effectiveness, benefits, or 
adverse events from differing doses, modes of administration, and the 
addition of opioids … For example, treatment of moderate to severe 
pain may require opioids, which present complications that
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
June 01, 2025 - In the case of opioids,8 serious potential harms include risk of opioid use disorder and overdose. … Opioids Pain Management 
Objective Testing Comparisons 
Monochromatic Infrared 
Photo Energy (MIRE); … of VER-01 to Opioids in Patients 
With Chronic Non-specific Low Back Pain 
VER-01; Opioid Therapy … CDC 
guideline for prescribing opioids for chronic 
pain– United States, 2016. … CDC 
guideline for prescribing opioids for chronic 
pain - United States, 2016.
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Community-Based Opioid Overdose Prevention Program 
(Project Lazarus) 
Unmet need: Increased prescribing of opioids … deaths associated with these pharmacologic agents.1 Illegal use of 
prescription pain relievers (i.e., opioids … For patients requiring chronic opioids for pain management or 
help with opioid dependence, treatment
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
January 01, 2010 - Intervention(s): Dopaminergic agents, antiparkinson agents, benzodiazepines and 
other sedative-hypnotics, opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
November 27, 2017 - Will that 
person keep the pt from using more opioids right 
away (since the pt will be dope-sick, but … This is especially relevant because of the 
dramatic rise in the abuse of high-potency 
opioids such … The urgency is 
further heightened by the rapid emergence of 
highly potent synthetic opioids, such as … The increased incidence 
of high potency opioids involved in an overdose 
will make the determination … We deleted the sentence 
discussing the proportion 
of heroin users who report 
prescription opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - The original 2020 report examined 
the evidence on the comparative effectiveness and harms of opioids … RCTs evaluated 
pharmacologic therapies and were included for KQ 2.4-6 There were no new studies on opioids … the original 2020 report and 
Surveillance Report 1 on the comparative effectiveness and harms of opioids … Opioids have low or insufficient strength of 
evidence for acute treatment of migraine. … SES]); (2) patient medical comorbidities (previous opioid use, 
body mass index [BMI]); (3) dose of opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
May 01, 2020 - Very few studies evaluated users of opioids, methamphetamines, or substances 
other than alcohol or cannabis
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - In contrast to Griebeler et al., we synthesized 
evidence on atypical opioids (tapentadol and 
tramadol … Otherwise, 
typical opioids are considered to be equivalent 
in efficacy for pain and have been treated … HELPFUL 
PARTCULATRLY AT NIGHT WITH SLEEP 
PROBLEMS; THERE NEEDS TO BE  SLOW 
TITRATION and atypical opioids … For tramadol and 
tapentadol, we report in the abstract that 
“opioids have significant long-term risks … and in the discussion, that 
“New guidelines and position papers now 
recommend against the use of opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - In contrast to Griebeler et al., we synthesized 
evidence on atypical opioids (tapentadol and 
tramadol … Otherwise, 
typical opioids are considered to be equivalent 
in efficacy for pain and have been treated … HELPFUL 
PARTCULATRLY AT NIGHT WITH SLEEP 
PROBLEMS; THERE NEEDS TO BE  SLOW 
TITRATION and atypical opioids … For tramadol and 
tapentadol, we report in the abstract that 
“opioids have significant long-term risks … and in the discussion, that 
“New guidelines and position papers now 
recommend against the use of opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/products/mhs4-opioid-stewardship/protocol
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-rept-1-acute-pain.xlsx
October 08, 2025 - B
Opioid use (mean [SD] tablets): 6.33 (7.1) vs. 5.69 (5.8), p=0.24
Consumed opioids postoperatively: … (1.90) vs. 1.84 (1.29) day 1, p=0.01; 3.14 (2.12) vs. 3.29 (2.14) day 7, p=0.17	NR	NR	
Escalated to opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
December 11, 2018 - benzodiazepines) 
topical agents,(diclofenac, lidocaine capsaicin) 
 Medical marijuana (any formulation) 
 Opioid … analgesics 
o Key Questions 1-4, 6, subquestion “c”: Exercise 
o Key Question 5, 6, subquestion “c” … and CBD); FDA 
approved synthetic cannabinoids 
(Dronabionol [THC], Nabilone [similar 
to THC]) 
• Opioid … analgesics 
KQs 1-4, 6 subquestion c 
• Exerciseb 
KQ 5, 6 subquestion c 
• Biofeedbackc 
All KQs: … Efficacy of opioids for chronic pain: a review of the evidence.
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
October 08, 2025 - discontinuation
49.3% (2650/5373) vs. 72.3% (3887/5373) p<0.001
Estimates of the odds ratio to cease opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
October 08, 2025 - discontinuation
49.3% (2650/5373) vs. 72.3% (3887/5373) p<0.001
Estimates of the odds ratio to cease opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0122_06-29-2009.pdf
January 01, 2009 - Comparator(s): no analgesic/anesthetic intervention, analgesia/anesthesia, systemic 
medications (such as opioids
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveillance-report-3.xlsx
January 01, 2021 - Table E-1. RCT QA
	Table E-1. RCT quality assessment 
	Author, Year	Randomization Adequate? 	Allocation Concealment Adequate?	Groups Similar at Baseline?	Outcome Assessors Masked?	Care Provider Masked?	Patient Masked?	Intention-To-Treat (ITT) Analysis	Acceptable Levels of Overall Attrition and Between-Group Differences… 
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveillance-report-2.xlsx
January 01, 2021 - Table E-1. RCT QA
	Table E-1. RCT quality assessment 
	Author,
Year	Randomization Adequate? 	Allocation Concealment Adequate?	Groups Similar at Baseline?	Outcome Assessors Masked?	Care Provider Masked?	Patient Masked?	Intention-To-Treat (ITT) Analysis	Acceptable Levels of Overall Attrition and Between-Group Differences…